JOURNAL ARTICLE

Patent Issued for Congestive obstruction pulmonary disease (COPD) (USPTO 12201349).

  • Published In: Mental Health Weekly Digest, 2025. P. 10225 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

A patent has been issued for a method to treat Congestive Obstructive Pulmonary Disease (COPD) using Irreversible Electroporation (IRE) to ablate diseased lung tissue. The patent, assigned to AngioDynamics Inc., aims to enhance lung function in patients with COPD by treating chronic bronchitis and emphysema. The method involves utilizing energy sources to ablate tissue through various electrode devices, with potential applications beyond lung tissue treatment. [Extracted from the article]

Additional Information

  • Source:Mental Health Weekly Digest. 2025/02, p10225
  • Document Type:Article
  • Subject Area:Consumer Health
  • Publication Date:2025
  • ISSN:1543-6616
  • Accession Number:182840403
  • Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.